Nordwand Advisors »

Oramed Pharm shares owned by Nordwand Advisors

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Nordwand Advisors from 13F filings

Historical chart of Nordwand Advisors investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Nordwand Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Nordwand Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.4k 1.0k 2.44

More positions owned by Nordwand Advisors

Berkshire Hathaway Inc Del Cl A (BRK.A)
Johnson & Johnson (JNJ)
Novocure Ord Shs (NVCR)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Income Etf (JPIE)
Grab Holdings Class A Ord (GRAB)
Harbor Etf Trust Internatnal Comp (OSEA)
Ardagh Metal Packaging S A SHS (AMBP)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Mp Materials Corp Com Cl A (MP)
Oaktree Specialty Lending Corp (OCSL)
Series Portfolios Tr Panagram Bbb B (CLOZ)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Nordwand Advisors

Top funds holding Oramed Pharm

BML Capital Management
Murchinson
Rathbones Brothers
Two Sigma Advisers
Renaissance Technologies
Bank of America Corporation
Two Sigma Investments
Susquehanna International
Connor, Clark & Lunn Investment Management
BlackRock
BlackRock
Squarepoint Ops
State Street Corporation
Jane Street
Dimensional Fund Advisors

View all funds holding Oramed Pharm